Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olaf Witt

Showing results (101-110 of 242) with videos related to

Pageof 25
Sort By:
The Journal of Clinical Investigation|March 16, 2011
An activated mutant BRAF kinase domain is sufficient to induce pilocytic astrocytoma in miceJan Gronych, Andrey Korshunov, Josephine Bageritz, et al.
Brain Pathology (Zurich, Switzerland)|May 10, 2012
Nestin expression identifies ependymoma patients with poor outcomeTill Milde, Thomas Hielscher, Hendrik Witt, et al.
Acta Neuropathologica Communications|April 9, 2015
Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastomaJonas Ecker, Ina Oehme, Ralph Mazitschek, et al.
Journal of Neuro-Oncology|November 24, 2023
Generation of patient-derived pediatric pilocytic astrocytoma in-vitro models using SV40 large T: evaluation of a modeling workflowFlorian Selt, Ahmed El Damaty, Martin U Schuhmann, et al.
Klinische Padiatrie|July 12, 2018
Molecular Diagnostics in Pediatric Brain Tumors: Impact on Diagnosis and Clinical Decision-Making - A Selected Case SeriesHeidi Bächli, Jonas Ecker, Cornelis van Tilburg, et al.
Cancers|September 10, 2021
Combining APR-246 and HDAC-Inhibitors: A Novel Targeted Treatment Option for NeuroblastomaMichael Müller, Lisa Rösch, Sara Najafi, et al.
Human Genetics|March 13, 2016
No correlation between NF1 mutation position and risk of optic pathway glioma in 77 unrelated NF1 patientsSonja Hutter, Rosario M Piro, Sebastian M Waszak, et al.
Neuro-Oncology Advances|September 24, 2020
Long-term cognitive deficits in pediatric low-grade glioma (LGG) survivors reflect pretreatment conditions-report from the German LGG studiesThomas Traunwieser, Daniela Kandels, Franz Pauls, et al.
Oncotarget|August 25, 2016
Low-dose Actinomycin-D treatment re-establishes the tumoursuppressive function of P53 in RELA-positive ependymomaTheophilos Tzaridis, Till Milde, Kristian W Pajtler, et al.
Genes, Chromosomes & Cancer|April 21, 2009
Novel oncogene amplifications in tumors from a family with Li-Fraumeni syndromeJuliane Rieber, Marc Remke, Christian Hartmann, et al.
Pageof 25

Showing results (101-110 of 242) with videos related to

Sort By:
Pageof 25
The Journal of Clinical Investigation|March 16, 2011
An activated mutant BRAF kinase domain is sufficient to induce pilocytic astrocytoma in miceJan Gronych, Andrey Korshunov, Josephine Bageritz, et al.
Brain Pathology (Zurich, Switzerland)|May 10, 2012
Nestin expression identifies ependymoma patients with poor outcomeTill Milde, Thomas Hielscher, Hendrik Witt, et al.
Acta Neuropathologica Communications|April 9, 2015
Targeting class I histone deacetylase 2 in MYC amplified group 3 medulloblastomaJonas Ecker, Ina Oehme, Ralph Mazitschek, et al.
Journal of Neuro-Oncology|November 24, 2023
Generation of patient-derived pediatric pilocytic astrocytoma in-vitro models using SV40 large T: evaluation of a modeling workflowFlorian Selt, Ahmed El Damaty, Martin U Schuhmann, et al.
Klinische Padiatrie|July 12, 2018
Molecular Diagnostics in Pediatric Brain Tumors: Impact on Diagnosis and Clinical Decision-Making - A Selected Case SeriesHeidi Bächli, Jonas Ecker, Cornelis van Tilburg, et al.
Cancers|September 10, 2021
Combining APR-246 and HDAC-Inhibitors: A Novel Targeted Treatment Option for NeuroblastomaMichael Müller, Lisa Rösch, Sara Najafi, et al.
Human Genetics|March 13, 2016
No correlation between NF1 mutation position and risk of optic pathway glioma in 77 unrelated NF1 patientsSonja Hutter, Rosario M Piro, Sebastian M Waszak, et al.
Neuro-Oncology Advances|September 24, 2020
Long-term cognitive deficits in pediatric low-grade glioma (LGG) survivors reflect pretreatment conditions-report from the German LGG studiesThomas Traunwieser, Daniela Kandels, Franz Pauls, et al.
Oncotarget|August 25, 2016
Low-dose Actinomycin-D treatment re-establishes the tumoursuppressive function of P53 in RELA-positive ependymomaTheophilos Tzaridis, Till Milde, Kristian W Pajtler, et al.
Genes, Chromosomes & Cancer|April 21, 2009
Novel oncogene amplifications in tumors from a family with Li-Fraumeni syndromeJuliane Rieber, Marc Remke, Christian Hartmann, et al.
Pageof 25